EcoDrugPlus

Protein Kinase C Beta

Ensembl ID : ENSFHEG00000004348
Gene Symbol: PRKCB
4 Cross references
213 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSFHEG00000002468
Gene Symbol: LOC105934050
3 Cross references
205 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSFHEG00000007356
Gene Symbol: PRKCD
3 Cross references
205 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSFHEG00000005191
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSFHEG00000006801
Gene Symbol: PRKCE
3 Cross references
250 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSFHEG00000008024
Gene Symbol: PRKCH
3 Cross references
223 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSFHEG00000009176
Gene Symbol: PRKCI
3 Cross references
270 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSFHEG00000009321
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSFHEG00000014264
Gene Symbol: PRKCZ
3 Cross references
205 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSFHEG00000011751
Gene Symbol: PRKD1
3 Cross references
210 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSFHEG00000008174
Gene Symbol: PRKD3
3 Cross references
218 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSFHEG00000021069
Gene Symbol: PRKDC
3 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).